Dedong Wu is an associate principal scientist in Advance Drug Delivery at AstraZeneca. He provides expertise in the areas of drug substance form selection, enabling formulation, targeted drug delivery...
Cheng received his BS in Chemistry at Xiamen University in 1984 and subsequently continued his Ph.D study at the Ohio State University from 1985-1990. He single handedly completed the...
Scott Shultz has over 20 years of pharmaceutical development experience at Merck in the process and analytical development areas. Since 2008 Scott has led numerous efforts in the materials...
Haitao Zhang is an Associate Research Fellow in Chemical Development with Sumitomo Pharma America since 2012. In the current role, he is responsible for in developing, and demonstrating commercially...
Dr. Fredrik Nordstrom leads a solid state and crystallization group within the Material and Analytical Science department at Boehringer-Ingelheim, Ridgefield, CT. The Solid State Chemistry group is responsible for...
Founder, SVP and CTO Center for Pharma Crystallization, J-Star Research ½Porton Pharma Solutions Dr. Jian Wang has 30 years of R&D experience in API crystallization, reaction and process engineering,...
Dr. Sun is Professor of Pharmaceutics in the Department of Pharmaceutics, University of Minnesota, USA. Dr. Sun’s research focuses on formulation development of tablet products through appropriate application of...
Dr. Yuriy Abramov is an industrial computational scientist with over 18 years experience at Pfizer Inc. Currently he holds a position of an Executive Director of computational chemistry and...
Currently Chief Technology Officer at Porton Pharmatech/J-Star Research, Inc. San Kiang is an SME in continuous processing API, continuous processing DP, particle engineering, pharmaceutical composite material, co-processing and pharmaceutical...
